Form 8.3 - WILLIS TOWERS WATSON PLC Amendment

LONDON--()-- 

Ap19

FORM 8.3 Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the

ORD

dealings being disclosed relate (Note 2)
Date of dealing

19 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,688,071

1.31%

164,070

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

7,100

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,766,530

1.37%

177,270

0.14%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

2

238.4675 USD

Purchase

3

238.7500 USD

Purchase

3

238.9200 USD

Purchase

4

239.3550 USD

Purchase

6

239.2600 USD

Purchase

8

238.3200 USD

Purchase

9

238.5300 USD

Purchase

10

238.9165 USD

Purchase

18

238.6583 USD

Purchase

18

238.8866 USD

Purchase

28

238.7819 USD

Purchase

75

238.2500 USD

Purchase

83

239.4700 USD

Purchase

100

239.0000 USD

Purchase

100

239.5050 USD

Purchase

100

239.4900 USD

Purchase

103

238.8700 USD

Purchase

269

240.3746 USD

Purchase

293

240.1028 USD

Purchase

293

240.1027 USD

Purchase

309

240.5839 USD

Purchase

385

238.9995 USD

Purchase

400

239.2523 USD

Purchase

476

239.2383 USD

Purchase

500

239.0473 USD

Purchase

833

238.9254 USD

Purchase

907

238.2045 USD

Purchase

2,474

238.5187 USD

Purchase

2,584

240.4000 USD

Purchase

2,603

239.4234 USD

Purchase

3,448

239.2521 USD

Purchase

3,641

238.0106 USD

Purchase

3,749

238.5805 USD

Purchase

6,052

238.9040 USD

Purchase

13,767

238.0100 USD

Purchase

38,699

238.4317 USD

Sale

1

240.1050 USD

Sale

1

239.1500 USD

Sale

2

238.8100 USD

Sale

3

239.7600 USD

Sale

4

239.9050 USD

Sale

4

239.6137 USD

Sale

7

239.1750 USD

Sale

7

239.0357 USD

Sale

8

238.3200 USD

Sale

10

238.9740 USD

Sale

10

239.3660 USD

Sale

12

239.2537 USD

Sale

12

239.2333 USD

Sale

17

238.8611 USD

Sale

19

239.0784 USD

Sale

19

238.9500 USD

Sale

89

238.8900 USD

Sale

100

239.5050 USD

Sale

100

238.9600 USD

Sale

124

238.7080 USD

Sale

143

238.9129 USD

Sale

200

238.9650 USD

Sale

208

238.8604 USD

Sale

244

238.9414 USD

Sale

269

240.3746 USD

Sale

293

240.1027 USD

Sale

293

240.1028 USD

Sale

300

238.8966 USD

Sale

433

238.9732 USD

Sale

490

239.3043 USD

Sale

576

238.8733 USD

Sale

587

239.0150 USD

Sale

800

238.0738 USD

Sale

993

240.3160 USD

Sale

1,049

238.9942 USD

Sale

1,695

239.4362 USD

Sale

2,021

238.1858 USD

Sale

2,584

240.4000 USD

Sale

3,643

238.0109 USD

Sale

5,002

238.8848 USD

Sale

5,656

238.9221 USD

Sale

5,953

238.0101 USD

Sale

7,083

238.0100 USD

Sale

40,527

238.4622 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

21 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 735664
Time of Receipt (offset from UTC): 20210421T133437+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC